Role of radiation therapy in the conservative management of sarcoma within an irradiated field

Eur J Surg Oncol. 2014 Feb;40(2):187-92. doi: 10.1016/j.ejso.2013.07.088. Epub 2013 Sep 26.

Abstract

Purpose: To report on clinical outcome and toxicity profile after combined treatment that included radiation therapy (RT) in patients with localized sarcoma within an irradiated field.

Patients and methods: Individual clinical data from all consecutive patients diagnosed and treated for a localized SIF between January 2000 and October 2011 at the Institut Claudius Regaud, Toulouse, France, were retrospectively reviewed. Outcomes of patients with SIF who underwent adjuvant or definitive radiotherapy were compared with patients who did not receive further RT.

Results: Of the 27 patients eligible for this study: surgery alone (S), surgery followed by RT (S + RT) or definitive RT (RT) was performed in 16, 8 and 2 cases respectively. The rate of unresectable, gross or microscopically positive margin disease among the 10 re-irradiated patients was significantly higher than the non re-irradiated group (90% vs. 12% p < 0.001). After a median follow-up of 3.8 years, there was a trend toward longer survival and better local control in the subgroup of patients who received adjuvant or definitive RT compared to the rest of the cohort with an acceptable toxicity profile. The 4-year relapse free survival rates of patients treated with and without RT were 53% and 27% respectively (p = 0.09).

Conclusion: SIF complete surgical resection is often difficult to achieve, enhancing the risk of relapse. RT should be discussed in case of unresectable tumor or after suboptimal surgery as part of intensified local management that has a curative intent.

Keywords: Functional outcome; Radiation therapy; Radio-induced sarcoma; Reirradiation; Sarcoma.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / radiotherapy*
  • Breast Neoplasms / surgery
  • Child
  • Child, Preschool
  • Cohort Studies
  • Combined Modality Therapy
  • Disease-Free Survival
  • Female
  • Head and Neck Neoplasms / drug therapy
  • Head and Neck Neoplasms / radiotherapy*
  • Head and Neck Neoplasms / surgery
  • Hemangiosarcoma / drug therapy
  • Hemangiosarcoma / radiotherapy
  • Hemangiosarcoma / surgery
  • Humans
  • Leiomyosarcoma / drug therapy
  • Leiomyosarcoma / radiotherapy
  • Leiomyosarcoma / surgery
  • Male
  • Middle Aged
  • Neoplasms, Radiation-Induced / drug therapy
  • Neoplasms, Radiation-Induced / radiotherapy*
  • Neoplasms, Radiation-Induced / surgery
  • Pelvic Neoplasms / drug therapy
  • Pelvic Neoplasms / radiotherapy*
  • Pelvic Neoplasms / surgery
  • Radiotherapy, Adjuvant
  • Retrospective Studies
  • Rhabdomyosarcoma / drug therapy
  • Rhabdomyosarcoma / radiotherapy
  • Rhabdomyosarcoma / surgery
  • Sarcoma / drug therapy
  • Sarcoma / radiotherapy*
  • Sarcoma / surgery
  • Treatment Outcome
  • Young Adult